Neoleukin Therapeutics In...

NASDAQ: NLTX · Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 10:00 PM

Neoleukin Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
136.59M 37.89M 142.47M
Short-Term Investments
175.82M 58.5M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
1.31M 936K 1.93M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
3.52M 2.75M 1.52M
Total Current Assets
315.92M 99.13M 143.99M
Property-Plant & Equipment
18.49M 15.88M 17.22M
Goodwill & Intangibles
n/a n/a 128K
Total Long-Term Assets
19.81M 16.81M 19.27M
Total Assets
335.73M 115.95M 163.26M
Account Payables
1.34M 478K 526K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
3M 1.51M 1.22M
Other Current Liabilities
10.82M 9.07M 6.89M
Total Current Liabilities
15.16M 11.06M 8.64M
Long-Term Debt
9.43M 10.55M 11.76M
Other Long-Term Liabilities
769K n/a n/a
Total Long-Term Liabilities
10.2M 10.55M 11.76M
Total Liabilities
25.36M 21.62M 20.4M
Total Debt
12.43M 12.07M 12.98M
Common Stock
n/a n/a n/a
Retained Earnings
-262.3M -451.06M -393.5M
Comprehensive Income
n/a -21K n/a
Shareholders Equity
310.38M 94.33M 142.86M
Total Investments
n/a 58.5M n/a